Mini-cancers Utilization as Decision Tools for Personalized Cancer Drug Regimens
Report of Invention:
12/2/2016
The present invention includes methods for identifying chemotherapy treatments specifically suited for each cancer patient. The methods include obtaining a biopsy from the cancer patient; establishing a cancer culture from the biopsy; mixing the cancer culture with a matrix forming mini cancers. The mini cancers are then used to screen chemotherapy agents by identifying those agents that completely stop mini cancer growth, inhibit mini cancer growth, and/or inhibit invasion of the mini cancers in a surrounding extracellular matrix. Since the mini cancers are derived from the patient, only the most effective chemotherapy agent(s) will be chosen to treat the cancer patient; minimizing the length of chemotherapy treatment, the cost of such treatments, and patient related illness.
Patent Information:
| Title |
App Type |
Country |
Serial No. |
Patent No. |
File Date |
Issued Date |
Expire Date |
Patent Status |
| Mini-cancers Utilization as Decision Tools for Personalized Cancer Drug Regimens |
PCT: Patent Cooperation Treaty |
PCT |
PCT/US2018/016356 |
|
2/1/2018 |
|
|
Expired |
| Mini-cancers Utilization as Decision Tools for Personalized Cancer Drug Regimens |
PCT: Patent Cooperation Treaty |
European Patent Office |
18748114.8 |
|
2/1/2018 |
|
|
Pending |
| MINI-CANCERS UTILIZATION FOR PERSONALIZED CANCER DRUG REGIMENS |
PCT: Patent Cooperation Treaty |
United States |
16/479,652 |
|
7/22/2019 |
|
|
Pending |
| MINI-CANCERS UTILIZATION FOR PERSONALIZED CANCER DRUG REGIMENS |
CIP: Continuation-in-part |
United States |
16/583,738 |
|
9/26/2019 |
|
|
Pending |
|
|
Inventors:
Get custom alerts for techs in these categories/from these inventors:
|
